Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
Clinical trial NCT07270835 · RECRUITING
Trial details
- NCT number
- NCT07270835
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2027-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.